中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2013年
5期
295-299
,共5页
孙青%卢强%崔丽英%邹漳钰%刘明生%钱敏%周雁%沈航%刘彩燕
孫青%盧彊%崔麗英%鄒漳鈺%劉明生%錢敏%週雁%瀋航%劉綵燕
손청%로강%최려영%추장옥%류명생%전민%주안%침항%류채연
僵人综合征%自身抗体%电生理学%谷氨酸脱羧酶%自身免疫疾病%预测
僵人綜閤徵%自身抗體%電生理學%穀氨痠脫羧酶%自身免疫疾病%預測
강인종합정%자신항체%전생이학%곡안산탈최매%자신면역질병%예측
Stiff-person syndrome%Autoantibodies%Electrophysiology%Glutamate decarboxylase%Autoimmune diseases%Forecasting
目的 总结僵人综合征(SPS)及变异型患者的临床特点及电生理特点,并对其伴发自身免疫病或肿瘤的概率以及抗谷氨酸脱羧酶(GAD)抗体滴度对临床症状严重程度及预后的预测价值进行分析.方法 收集北京协和医院2001-2012年诊断为SPS的8例患者的临床与辅助检查资料,并进行Rankin评分和统计伴发自身免疫病或肿瘤的概率;应用SPSS 17.0软件对抗GAD抗体滴度与临床症状严重程度、治疗效果的关系进行统计学分析.结果 8例SPS患者中7例主要表现为躯干和下肢强直痉挛.6例行针极肌电图检查,4例可见安静状态下持续的运动单位电位活动,其中以躯干肌最明显.4例行脑电图检查,均无异常癫痫样放电.7例行抗GAD抗体检查,5例呈阳性,其中3例伴发糖尿病,4例伴发甲状腺疾病,1例伴发肿瘤;2例呈阴性,无伴发糖尿病,1例伴发甲状腺疾病,1例伴发肿瘤.血抗GAD抗体滴度>2.000×106 U/L者治疗前Rankin评分分别为5、4、4分,治疗后分别改善1、2、2分,血抗GAD抗体滴度<2.000×106 U/L者治疗前评分为4、4分,治疗后分别改善2、2分,两者治疗前Rankin评分差异无统计学意义(U =2.000,P=0.414),治疗后评分改善程度差异无统计学意义(U=2.000,P=0.414).结论 SPS患者临床上主要表现为以躯干为主的肌肉僵硬、痉挛,肌电图上表现为安静状态下主动肌和拮抗肌持续的运动单位电位活动.抗GAD抗体滴度对临床症状严重程度及预后可能不具有预测价值,但根据抗GAD抗体是否阳性对SPS患者进行分类,有助于预测患者合并自身免疫病及肿瘤的风险.
目的 總結僵人綜閤徵(SPS)及變異型患者的臨床特點及電生理特點,併對其伴髮自身免疫病或腫瘤的概率以及抗穀氨痠脫羧酶(GAD)抗體滴度對臨床癥狀嚴重程度及預後的預測價值進行分析.方法 收集北京協和醫院2001-2012年診斷為SPS的8例患者的臨床與輔助檢查資料,併進行Rankin評分和統計伴髮自身免疫病或腫瘤的概率;應用SPSS 17.0軟件對抗GAD抗體滴度與臨床癥狀嚴重程度、治療效果的關繫進行統計學分析.結果 8例SPS患者中7例主要錶現為軀榦和下肢彊直痙攣.6例行針極肌電圖檢查,4例可見安靜狀態下持續的運動單位電位活動,其中以軀榦肌最明顯.4例行腦電圖檢查,均無異常癲癇樣放電.7例行抗GAD抗體檢查,5例呈暘性,其中3例伴髮糖尿病,4例伴髮甲狀腺疾病,1例伴髮腫瘤;2例呈陰性,無伴髮糖尿病,1例伴髮甲狀腺疾病,1例伴髮腫瘤.血抗GAD抗體滴度>2.000×106 U/L者治療前Rankin評分分彆為5、4、4分,治療後分彆改善1、2、2分,血抗GAD抗體滴度<2.000×106 U/L者治療前評分為4、4分,治療後分彆改善2、2分,兩者治療前Rankin評分差異無統計學意義(U =2.000,P=0.414),治療後評分改善程度差異無統計學意義(U=2.000,P=0.414).結論 SPS患者臨床上主要錶現為以軀榦為主的肌肉僵硬、痙攣,肌電圖上錶現為安靜狀態下主動肌和拮抗肌持續的運動單位電位活動.抗GAD抗體滴度對臨床癥狀嚴重程度及預後可能不具有預測價值,但根據抗GAD抗體是否暘性對SPS患者進行分類,有助于預測患者閤併自身免疫病及腫瘤的風險.
목적 총결강인종합정(SPS)급변이형환자적림상특점급전생리특점,병대기반발자신면역병혹종류적개솔이급항곡안산탈최매(GAD)항체적도대림상증상엄중정도급예후적예측개치진행분석.방법 수집북경협화의원2001-2012년진단위SPS적8례환자적림상여보조검사자료,병진행Rankin평분화통계반발자신면역병혹종류적개솔;응용SPSS 17.0연건대항GAD항체적도여림상증상엄중정도、치료효과적관계진행통계학분석.결과 8례SPS환자중7례주요표현위구간화하지강직경련.6례행침겁기전도검사,4례가견안정상태하지속적운동단위전위활동,기중이구간기최명현.4례행뇌전도검사,균무이상전간양방전.7례행항GAD항체검사,5례정양성,기중3례반발당뇨병,4례반발갑상선질병,1례반발종류;2례정음성,무반발당뇨병,1례반발갑상선질병,1례반발종류.혈항GAD항체적도>2.000×106 U/L자치료전Rankin평분분별위5、4、4분,치료후분별개선1、2、2분,혈항GAD항체적도<2.000×106 U/L자치료전평분위4、4분,치료후분별개선2、2분,량자치료전Rankin평분차이무통계학의의(U =2.000,P=0.414),치료후평분개선정도차이무통계학의의(U=2.000,P=0.414).결론 SPS환자림상상주요표현위이구간위주적기육강경、경련,기전도상표현위안정상태하주동기화길항기지속적운동단위전위활동.항GAD항체적도대림상증상엄중정도급예후가능불구유예측개치,단근거항GAD항체시부양성대SPS환자진행분류,유조우예측환자합병자신면역병급종류적풍험.
Objective To demonstrate the clinical and electrophysiological characteristics of stiffperson syndrome (SPS) and variants,investigate the frequency of coexisting autoimmune disease and cancer,and determine the correlation between anti-glutamic acid decarboxylase (GAD) antibody titers and severity and outcome of the disease.Methods Clinical and electrophysiological data of 8 SPS patients of Peking Union Medical College Hospital between 2001 and 2012 were collected.We used Rankin Scale to score and count the probability of coexisting autoimmune disease and cancer,and used SPSS 17.0 to analyze the correlation between anti-GAD antibody titers,severity and outcome of the disease.Results Seven out of the 8 SPS patients were rigidity and spasms of trunk and lower extremities.Four out of the 6 patients underwent electromyography examination showed evidence of continuous motor unit activity,especially in paraspinal muscles.None of the 4 patients underwent electroencephalography examination showed epileptiform discharges.Five of the 7 patients underwent anti-GAD antibody examination were seropositive.Among these GAD antibody seropositive patients,3 patients had diabetes mellitus,4 patients had thyroid disease,and 1 had coexisting cancer.Among the 2 anti-GAD antibody seronegative patients,none of them had diabetes mellitus,1 had thyroid disease,and 1 had coexisting cancer.Among the patients whose antiGAD antibody titers were more than 2.000 × 106 U/L,the Rankin scores before treatment were 5,4,4 respectively,and the Rankin scores improvement after treatment were 1,2,2 respectively.Among the patients whose anti-GAD antibody titers were less than 2.000 × 106 U/L,the Rankin scores before treatment were 4,4 respectively,and the Rankin scores improvement after treatment were 2,2 respectively.Between the patients with anti-GAD antibody titers less than and more than 2.000 ×106 U/L,the Rankin scores before treatment had no significant difference (U =2.000,P =0.414),and the Rankin scores improvement after treatment had no significant difference (U =2.000,P =0.414).Conclusions The main clinical manifestations of SPS patients are rigidity and painful spasms of axial muscles,and electromyography examination shows evidence of continuous motor unit activity.Anti-GAD antibody titers may have no practical value in predicting the severity and outcome of SPS,but classification by anti-GAD antibody serostatus may be useful for predicting the risk of coexisting autoimmune disease and cancer.